Our previous work indicates that the combination of RT and chemotherapy with docetaxel alters the immune phenotype of HNSCC tumor cells, characterized by increased surface expression of CD137-L and release of HMGB1 of specifically HPV-positive tumor cells9. The gene discussed is HMGB1; the disease is neoplasm.